As an engineer, I would want to collect data about the particular standard deviations for both groups in the trials. Find out what they have in common within their subgroups. If one has no response it is not a problem, those that over respond, can be given lighter doses during second trials to measure response. Of course consumers will double up on their own if they like it, but the prescribing physicians or psychiatrists may measure. I see no problem so far except with altering data, big pharma doesn't even bother with testing much and the FDA allows an assumption of acceptability based on the manufacturer. All speed ahead, just measure out and do independent testing I would say. Isabella, blabs they are back together again, wow. Ok, MC *wink* has been creampieing most of them. I expect the resolution was going to be her having all the ladies test a sample to compare results from a closed group. I would be looking at blood types, ages, and varying placebos were not mentioned in the clinical trials either. In some studies, the volunteers, will stay for several days in a controlled environment, with varying stimulating situations recording moods, and using survey data.
Last edited:
